1. Quick and convenient construction of lambda-cyhalothrin antigen for the generation of specific antibody.
- Author
-
Cui N, Cao L, Sui J, Lin H, Han X, Chen X, Xie H, and Sun X
- Subjects
- Animals, Antibodies chemistry, Antigen-Antibody Reactions, Antigens chemistry, Enzyme-Linked Immunosorbent Assay, Female, Haptens analysis, Mice, Mice, Inbred BALB C, Molecular Structure, Nitriles analysis, Nitriles chemical synthesis, Pyrethrins analysis, Pyrethrins chemical synthesis, Antibodies immunology, Antigens immunology, Haptens immunology, Nitriles immunology, Pyrethrins immunology
- Abstract
Lambda-cyhalothrin is a pyrethroid widely used in crop, fruit and vegetable production, but has potential health threats to human. Immunoassay is a cheap, rapid and facile method to detect lambda-cyhalothrin, yet wide application of this method still requires improvement in the construction of antigen. In this study, we developed a one-step lambda-cyhalothrin hapten synthesis that transformed the cyanide group in lambda-cyhalothrin to amide. Complete antigen was assembled by coupling the amide with succinic-anhydride-activated carrier proteins, and corresponding polyclonal antibodies were generated using Balb/c mice. Using antibody generated by the method in this paper, the competitive ELISA demonstrated the lowest detection limit of 3.772 μg/L for lambda-cyhalothrin, and no significant cross-reactivity for other pyrethroid pesticides was observed. All the results suggested we have established a more efficient technique of generating lambda-cyhalothrin antibody. Furthermore, since the activated proteins used in this study are highly controllable, we believe these proteins could potentially be the prototype of a series of standardized carrier proteins for the synthesis of complete antigens., Competing Interests: Declaration of competing interest The authors have filed a patent application covering the synthesis of hapten and protein activation: Chinese patent application no. 201911291688.2., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF